IL-4 drives exhaustion of CD8 ⁺ CART cells.

Autor: Stewart CM; T Cell Engineering, Mayo Clinic, Rochester, MN, USA.; Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN, USA.; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA., Siegler EL; T Cell Engineering, Mayo Clinic, Rochester, MN, USA.; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Sakemura RL; T Cell Engineering, Mayo Clinic, Rochester, MN, USA.; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Cox MJ; T Cell Engineering, Mayo Clinic, Rochester, MN, USA., Huynh T; T Cell Engineering, Mayo Clinic, Rochester, MN, USA.; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Kimball B; T Cell Engineering, Mayo Clinic, Rochester, MN, USA.; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Mai L; T Cell Engineering, Mayo Clinic, Rochester, MN, USA.; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Can I; T Cell Engineering, Mayo Clinic, Rochester, MN, USA.; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Manriquez Roman C; T Cell Engineering, Mayo Clinic, Rochester, MN, USA., Yun K; T Cell Engineering, Mayo Clinic, Rochester, MN, USA.; Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN, USA.; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, USA., Sirpilla O; T Cell Engineering, Mayo Clinic, Rochester, MN, USA.; Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN, USA.; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA., Girsch JH; T Cell Engineering, Mayo Clinic, Rochester, MN, USA.; Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN, USA.; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, USA., Ogbodo E; T Cell Engineering, Mayo Clinic, Rochester, MN, USA.; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Mohammed Ismail W; Department of Lab Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Gaspar-Maia A; Department of Lab Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Budka J; Department of Oncology, Gilead Sciences Inc., Foster City, CA, USA., Kim J; Department of Oncology, Gilead Sciences Inc., Foster City, CA, USA., Scholler N; Department of Oncology, Gilead Sciences Inc., Foster City, CA, USA., Mattie M; Department of Oncology, Gilead Sciences Inc., Foster City, CA, USA., Filosto S; Department of Oncology, Gilead Sciences Inc., Foster City, CA, USA., Kenderian SS; T Cell Engineering, Mayo Clinic, Rochester, MN, USA. kenderian.saad@mayo.edu.; Division of Hematology, Mayo Clinic, Rochester, MN, USA. kenderian.saad@mayo.edu.; Department of Immunology, Mayo Clinic, Rochester, MN, USA. kenderian.saad@mayo.edu.

Publikováno v: Nature communications [Nat Commun] 2024 Sep 12; Vol. 15 (1), pp. 7921. Date of Electronic Publication: 2024 Sep 12.

CCR5 delta 32 gene, innunoglobulins, lipid and other biochemical parameters in HIV discordant couples in Plateau State, Nigeria

Autor: Meludu, S., Duru, B., Onah, C., Ogbodo, E.

Publikováno v: In Clinica Chimica Acta 1 May 2024 558 Supplement 1

Assessment of the Patterns of Immunoglobulin G and M Levels in HIV Serodiscordant Couples

Autor: Nnamdi, Duru B., Chukwuemeka, Meludu S., Chukwuemeka, Ogbodo E., Ejike, Onah C., Friday, Ehiaghe A., Bridget, Onyema-iloh O., Clement, Amaifeobu, Emmanuel, Mbam R.

Publikováno v: INTERNATIONAL JOURNAL OF APPLIED PHARMACEUTICAL SCIENCES AND RESEARCH; Vol 8 No 01 (2023): International Journal of Applied Pharmaceutical Sciences and Research; 1-7

This longitudinal study assessed the patterns of immunoglobulin G and M levels in HIV serodiscordant couples. A total of20 serodiscordant HIV couples (40 patients) and 20 controls (40 HIV seronegative couples) were randomly recruited forthe study. Fi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=sierrajourna::e36536ee53a41b94b36e98706985f5a7
https://www.sierrajournals.com/index.php/IJAPSR/article/view/1081

Evaluation of Some Cardiovascular Markers in Lead- Recycling Factory Workers

Autor: Ejike, Onah C., Florence, Onah C., Michael, Oliseh C., J, Nnodim, Athanasius, Onyegbule O., Ukamaka, Ijeomah A., Chukwuemeka, Meludu S., Emmanuel, Dioka C., Chukwuemeka, Ogbodo E.

Publikováno v: INTERNATIONAL JOURNAL OF APPLIED PHARMACEUTICAL SCIENCES AND RESEARCH; Vol 7 No 04 (2022): International Journal of Applied Pharmaceutical Sciences and Research; 66-71

Lead is a naturally occurring metal that has no known safe blood concentration. This study was designed to assess theblood pressure, body mass index, fasting lipid profile and plasma glucose levels, and cardiac enzyme activity in leadrecyclingfactory

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=sierrajourna::714958d53bb643f07b9aded6f2b4b72d
https://www.sierrajournals.com/index.php/IJAPSR/article/view/1079

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.